For: | Pleguezuelo M, Lopez-Sanchez LM, Rodriguez-Ariza A, Montero JL, Briceno J, Ciria R, Muntane J, Mata ML. Proteomic analysis for developing new biomarkers of hepatocellular carcinoma. World J Hepatol 2010; 2(3): 127-135 [PMID: 21160983 DOI: 10.4254/wjh.v2.i3.127] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v2/i3/127.htm |
Number | Citing Articles |
1 |
Da‐Ni Zhong, Qiu‐Yue Ning, Ji‐Zhou Wu, Ning Zang, Jian‐Lin Wu, Die‐Fei Hu, Shuang‐Yan Luo, Ai‐Chun Huang, Lan‐Lan Li, Guo‐Jian Li. Comparative proteomic profiles indicating genetic factors may involve in hepatocellular carcinoma familial aggregation. Cancer Science 2012; 103(10): 1833 doi: 10.1111/j.1349-7006.2012.02368.x
|
2 |
M.R. Ghahramani, A.A. Garibov, T.N. Agayev. Production and quality control of radioactive yttrium microspheres for medical applications. Applied Radiation and Isotopes 2014; 85: 87 doi: 10.1016/j.apradiso.2013.12.009
|
3 |
Yuji Morine, Tohru Utsunomiya, Hisami Yamanaka-Okumura, Yu Saito, Shinichiro Yamada, Tetsuya Ikemoto, Satoru Imura, Shohei Kinoshita, Akiyoshi Hirayama, Yasuhito Tanaka, Mitsuo Shimada. Essential amino acids as diagnostic biomarkers of hepatocellular carcinoma based on metabolic analysis. Oncotarget 2022; 13(1): 1286 doi: 10.18632/oncotarget.28306
|
4 |
Manar Mahmoud El-Tonsy, Hesham Mohammed Hussein, Thanaa El-Sayed Helal, Rania Ayman Tawfik, Khalid Mohamed Koriem, Hend Mohamed Hussein. Schistosoma mansoni infection: Is it a risk factor for development of hepatocellular carcinoma?. Acta Tropica 2013; 128(3): 542 doi: 10.1016/j.actatropica.2013.07.024
|
5 |
Manar Mahmoud El-Tonsy, Hesham Mohammed Hussein, Thanaa El-Sayed Helal, Rania Ayman Tawfik, Khalid Mohamed Koriem, Hend Mohamed Hussein. Human Schistosomiasis mansoni associated with hepatocellular carcinoma in Egypt: current perspective. Journal of Parasitic Diseases 2016; 40(3): 976 doi: 10.1007/s12639-014-0618-0
|
6 |
Ashraf Khalil, Ashraf Elfert, Samar Ghanem, Marwa Helal, Shymaa Abdelsattar, Gamalate Elgedawy, Manar Obada, Mohamed Abdel-Samiee, Hala El-Said. The role of metabolomics in hepatocellular carcinoma. Egyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00085-9
|
7 |
Hasan El Garem, Gamal Esmat, Rabab Salama, Hanan Fouad, Dina Sabry, Yomna Mostafa, Dalia Omran, Heba Omar. Noninvasive prediction of hepatitis C-associated hepatocellular carcinoma using circulating apolipoproteins. The Egyptian Journal of Internal Medicine 2019; 31(4): 451 doi: 10.4103/ejim.ejim_26_19
|
8 |
Gul M Mustafa, Denner Larry, John R Petersen, Cornelis J Elferink. Targeted proteomics for biomarker discovery and validation of hepatocellular carcinoma in hepatitis C infected patients. World Journal of Hepatology 2015; 7(10): 1312-1324 doi: 10.4254/wjh.v7.i10.1312
|
9 |
Asem I Fitian, Roniel Cabrera. Disease monitoring of hepatocellular carcinoma through metabolomics. World Journal of Hepatology 2017; 9(1): 1-17 doi: 10.4254/wjh.v9.i1.1
|
10 |
Zhong-Chen Li, Jie Wang, He-Bin Liu, Yi-Min Zheng, Jian-Hang Huang, Jia-Bin Cai, Lei Zhang, Xin Liu, Ling Du, Xue-Ting Yang, Xiao-Qiang Chai, Ying-Hua Jiang, Zheng-Gang Ren, Jian Zhou, Jia Fan, De-Cai Yu, Hui-Chuan Sun, Cheng Huang, Feng Liu. Proteomic and metabolomic features in patients with HCC responding to lenvatinib and anti-PD1 therapy. Cell Reports 2024; 43(3): 113877 doi: 10.1016/j.celrep.2024.113877
|